Your browser doesn't support javascript.
loading
Production of MSTN-mutated cattle without exogenous gene integration using CRISPR-Cas9.
Gim, Gyeong-Min; Kwon, Dong-Hyeok; Eom, Kyeong-Hyun; Moon, JoonHo; Park, Ji-Hyun; Lee, Won-Wu; Jung, Dae-Jin; Kim, Dae-Hyun; Yi, Jun-Koo; Ha, Jae-Jung; Lim, Ka-Yeong; Kim, Jin-Soo; Jang, Goo.
Affiliation
  • Gim GM; Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, Republic of Korea.
  • Kwon DH; BK21 Plus Program, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
  • Eom KH; Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, Republic of Korea.
  • Moon J; BK21 Plus Program, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
  • Park JH; Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Science, College of Veterinary Medicine and the Research Institute of Veterinary Science, Seoul National University, Seoul, Republic of Korea.
  • Lee WW; BK21 Plus Program, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
  • Jung DJ; LARTBio Inc., Seoul, Republic of Korea.
  • Kim DH; LARTBio Inc., Seoul, Republic of Korea.
  • Yi JK; LARTBio Inc., Seoul, Republic of Korea.
  • Ha JJ; Gyeongsangbukdo Livestock Research Institute, Yeongju, Republic of Korea.
  • Lim KY; Gyeongsangbukdo Livestock Research Institute, Yeongju, Republic of Korea.
  • Kim JS; Gyeongsangbukdo Livestock Research Institute, Yeongju, Republic of Korea.
  • Jang G; Gyeongsangbukdo Livestock Research Institute, Yeongju, Republic of Korea.
Biotechnol J ; 17(7): e2100198, 2022 Jul.
Article in En | MEDLINE | ID: mdl-34247443
ABSTRACT
Many genome-edited animals have been produced using clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology to edit specific genes. However, there are few guidelines for the application of this technique to cattle. The goal of this study was to produce trait-improved cattle using the genome-editing technology CRISPR-Cas9. Myostatin (MSTN) was selected as a target locus, and synthetic mRNA of sgRNA and Cas9 were microinjected into fertilized bovine embryos in vitro. As a result, 17 healthy calves were born, and three of them showed MSTN mutation rates of 10.5%, 45.4%, and 99.9%, respectively. Importantly, the offspring with the 99.9% MSTN mutation rate had a biallelic mutation (-12 bps) and a double-muscling phenotype. In conclusion, we demonstrate that the genome-editing technology CRISPR-Cas9 can produce genetically modified calves with improved traits.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myostatin / CRISPR-Cas Systems Limits: Animals Language: En Journal: Biotechnol J Journal subject: BIOTECNOLOGIA Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myostatin / CRISPR-Cas Systems Limits: Animals Language: En Journal: Biotechnol J Journal subject: BIOTECNOLOGIA Year: 2022 Document type: Article